Jakob Dupont - Insider Trading & Ownership

Location
C/O Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City, CA
Summary
The estimated net worth of Jakob Dupont is at least $149K dollars as of July 2, 2025. Jakob Dupont is the EVP, Head of R&D of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $113K. Jakob Dupont is the Director of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $36.2K.
Signature
/s/ William P. Quinn, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Jakob Dupont

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ATRA Atara Biotherapeutics, Inc. EVP, Head of R&D $113K Mar 2, 2023
PYXS Pyxis Oncology, Inc. Director $36.2K Mar 31, 2025
APGN Apexigen, Inc. Director Aug 23, 2023
BOLT Bolt Biotherapeutics, Inc. Director May 27, 2025

Insider Transactions Reported by Jakob Dupont:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.